Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA||030M20A / 2||RA / IM|
Administered by: Private Purchased by: ??
Symptoms: Headache, Rhinorrhoea, Respiratory tract congestion, Oropharyngeal pain, COVID-19, SARS-CoV-2 test positive
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? Yes
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data: POCT SARS-COV-2 Rapid: SARS-COV-2 detected (7/8/2021)
CDC 'Split Type':
Write-up: Pt is 36 yo male, employee at this institution. He is s/p Moderna COVID-19 full vaccination: first dose on 1/2/2021, second dose on 2/9/2021. Underwent voluntary COVID-19 rapid testing on 7/8 after experiencing symptoms including headache, sore throat, and congestion/runny nose. Pt reported possible exposure to COVID-19. Rapid test resulted positive. Patient advised to self-isolate for 10 days after symptom onset and contacted by local health department.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166